EUVIMEDEUVIMED entdecken
Crossref

Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls

Dorte Glintborg iD, Jens-Jakob Kjer Møller, Katrine Hass Rubin, Øjvind Lidegaard, Guy T'Sjoen, Mie-Louise Julie Ørsted Larsen, Malene Hilden, Marianne Skovsager Andersen

The Journal of Clinical Endocrinology & Metabolism · 18.11.2024 · 109 (12) · 3076-3086

DOI: 10.1210/clinem/dgae351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.05.2024. Verfasst von Dorte Glintborg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Odense University Hospital, Odense 5000, Denmark. Hauptthemen laut MEDLINE: Transgender Persons, Employment, Gender Dysphoria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: University Hospital, Forskningsrådet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Gender-affirming care could be associated with higher employment rate. We assessed employment rates in transgender persons compared to controls and demographic, health, and treatment-related factors associated with employment in transgender persons.

Methods

National register-based cohort study in Danish persons with diagnosis code of gender dysphoria during year 2000-2021. Five age-matched controls of the same sex at birth and 5 age-matched controls of the other sex at birth were included. The date of study inclusion was the first date of transgender diagnosis. Employment was the primary study outcome.

Results

The cohort included 3812 transgender persons and 38 120 cisgender controls. The median age (interquartile range) was 19 (15; 24) years for transgender men, n = 1993 and 23 (19; 33) years for transgender women, n = 1819. In transgender men compared to control cisgender women, the odds ratio (OR) (95% CI) for employment was 0.33 (0.29; 0.38) before study inclusion and 0.24 (0.20; 0.29) in the fifth calendar year after index; in transgender women compared to control cisgender men, corresponding ORs were 0.30 (0.70; 0.34) and 0.21 (0.18; 0.25). Similar findings were observed between transgender persons and cisgender controls of other sex. Use of gender-affirming hormone in transgender men increased probability of employment at all time points after 5 years (OR 1.61 [95% CI: 1.08; 2.42], P = .02). In transgender women, use of hormone treatment was not associated with changed employment rates at 5 years (OR 1.31 [0.94; 1.82], P = .11).

Conclusion

Masculinizing hormone treatment was associated with higher probability of employment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsEmploymentGender DysphoriaHumansMaleFemaleDenmarkAdultYoung AdultAdolescentCase-Control StudiesRegistriesCohort StudiesGender-Affirming Procedures

Stichwörter der Autor:innen

gender-affirming hormonemedicine prescriptionmental healthregister-basedsocioeconomic statustransgender

Autor:innen und Institutionen

  • Department of Endocrinology, Odense University Hospital, Odense 5000, Denmark.
  • Institute of Clinical Research, University of Southern Denmark, Odense 5000, Denmark.
  • OPEN-Open Patient Data Explorative Network, Odense University Hospital, Odense 5000, Denmark.
  • Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark.
  • Department of Gynaecology, Fertility and Obstetrics, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen 2100, Denmark.

ORCID-Profile: Dorte Glintborg

Förderung

  • University Hospital
  • Forskningsrådet

Zitieren

APA

Glintborg, D., Møller, J. K., Rubin, K. H., Lidegaard, Ø., T'Sjoen, G., Larsen, M. J. Ø., Hilden, M., & Andersen, M. S. (2024). Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls. The Journal of Clinical Endocrinology & Metabolism, 109(12), 3076-3086. https://doi.org/10.1210/clinem/dgae351

Vancouver

Glintborg D, Møller JK, Rubin KH, Lidegaard Ø, T'Sjoen G, Larsen MJØ, et al. Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls. The Journal of Clinical Endocrinology & Metabolism. 2024;109(12):3076-3086. doi:10.1210/clinem/dgae351

BibTeX
@article{Glintborg2024,
  author = {Glintborg, Dorte and Møller, Jens-Jakob Kjer and Rubin, Katrine Hass and Lidegaard, Øjvind and T'Sjoen, Guy and Larsen, Mie-Louise Julie Ørsted and Hilden, Malene and Andersen, Marianne Skovsager},
  title = {Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {12},
  pages = {3076--3086},
  doi = {10.1210/clinem/dgae351}
}
Kostenlos starten →